Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rinku.y8448@gmail.com
    Junior Member
    • Sep 2015
    • 7

    #1

    SNP analysis

    Dear All,
    i am currently doing variant analysis of NF2 ,after visualisation the result ,but i am confuse my result is it correct or not? and also i couldn't find the no. of snp , rather i check the another site dbsnp , i put individually gene i.d for search but no answere has come. plz tell me how can i do it step by step?
    and also how can i identify the result or no.of snp ?
    I doubt it's a pretty and complicaited question but i am hopefull that you people can help me to sort this out..
    hoping fir a positive rply asap
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    @rinku: Perhaps the question as posted above is clear to you but I can't understand what exactly you are asking. Can you clarify?

    Comment

    • rinku.y8448@gmail.com
      Junior Member
      • Sep 2015
      • 7

      #3
      @genomax: my question is how to do vairant anaylsis of schwannomatosis @ how to find the no. of snp ?

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        Did your "variant analysis" include some sort of alignment/calling SNP's (in NF2 gene) using your own NGS data? Or are you just trying to find all known SNP's for NF2 from dbSNP?

        Comment

        • rinku.y8448@gmail.com
          Junior Member
          • Sep 2015
          • 7

          #5
          @genomax: yes i am trying to find snp how ?

          Comment

          • GenoMax
            Senior Member
            • Feb 2008
            • 7142

            #6
            For known SNP's for NF2 a simple search for dbSNP can be done like this: http://www.ncbi.nlm.nih.gov/snp/?term=NF2 You can also look at "gene view": http://www.ncbi.nlm.nih.gov/projects...gi?geneId=4771 or Variation viewer (search for NF2): http://www.ncbi.nlm.nih.gov/variation/view/

            Comment

            • rinku.y8448@gmail.com
              Junior Member
              • Sep 2015
              • 7

              #7
              @genomax: thankyou....u helpd me.now i'll sort out it....
              thankyou so much ,

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                by SEQadmin2



                CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                Despite this, “CRISPR helped turn genome editing from a specialized technique into
                ...
                07-31-2026, 11:01 AM
              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                07-20-2026, 11:48 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, 08-03-2026, 10:13 AM
              0 responses
              15 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-31-2026, 02:55 AM
              0 responses
              32 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-24-2026, 12:17 PM
              0 responses
              23 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-23-2026, 11:41 AM
              0 responses
              21 views
              0 reactions
              Last Post SEQadmin2  
              Working...